Download Ocean Medicine

H2020 – MSCA – RISE: OCEAN MEDICINES
9 partners, 4 years project
Ocean Medicines is a network of academic, research centres and SMEs across Europe, with
proven experience in higher education, training and endowed with state of the art
scientific and technical expertise and infrastructures. Our aim is to establish a network
of collaboration and knowledge- exchange between industrial and academic partners to
further develop lead compounds from marine microorganisms having anticancer or antiinfective effects that have already been identified by the consortium. To achieve this goal
a mobility programme will be set up to prepare a new generation of marine biodiscovery
scientists that will be trained on how to isolate compounds from bioactive
bacteria/microalgae and take these through to semi-industrial scale-up for further
development and toxicity testing at the pre-clinical level. The Ocean Medicines
programme also considers commercialization, innovation and entrepreneurship activities
including how to start a new business and how to favour an industrial career to
seconded researchers. We are confident that the establishment of this international
research network, with its synergistic effects, will significantly contribute to advance all
of the involved labs to the top level in the field of marine drug discovery.
Most of the participants (IBP-CNR, SZN, UiT, UNIABDN, UWC, eCoast, and MEDINA) are
currently participating in an onNgoing FP7 funded project: PharmaSea which is a large
collaborative project with 24 partners focused on the marine biodiscovery
pharmaceutical pipeline that also includes research in the antinflammatory and antineurodenegerative fields. IBP-CNR, SZN and UNIABDN are also members of the
Pharmadeep consortium aimed at sampling deep-sea trenches in Sub-Antarctic areas for
the discovery of new pharmaceuticals.